Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Franklin Asian Equity Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseFranklinHDFC
NAV₹45.3436₹23.6750
NAV date19 Nov 202620 Nov 2026
History13.9 years3.1 years
Expense ratio1.2%1.1%
Stars★★★★★★★★★★
Growth Score65.1094.50

Returns

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
1 month−1.78%+12.97%
3 months−8.66%+7.13%
6 months−3.66%+17.84%
YTD+16.21%+33.73%
1 year+20.98%+32.20%
3 years (CAGR)+19.44%+30.70%
5 years (CAGR)+6.81%—
10 years (CAGR)+10.32%—
Since launch+9.32%+31.83%

Risk

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
Volatility17.7%15.8%
Downside volatility10.4%8.5%
Sharpe0.731.53
Sortino1.252.86
Calmar1.372.06
Return / risk1.101.95
Deepest fall−40.20%−14.91%
Days to recover1074126
Below its high−11.70%+0.00%

Against benchmark

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
Alpha+10.56%+7.54%
Beta0.510.97
R²21.3%85.0%
Up capture69.9%108.9%
Down capture1.9%71.0%
Tracking error17.6%6.1%
Information ratio0.451.17
Treynor0.260.24

Consistency

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
Best 1-year+71.57%+67.01%
Middle 1-year+10.63%+23.25%
Worst 1-year−32.93%+1.71%
1-year periods with a loss26.1%0.0%
Middle 3-year+8.99%+30.22%
Positive months58.3%72.2%
Best day+5.04%+3.18%
Worst day−6.66%−3.61%
Worst 5% day−1.67%−1.51%
Positive days56.9%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
5-year XIRR+15.08%—
5-year value₹8,81,338—
3-year XIRR+19.77%+27.71%
1-year XIRR+4.81%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth